Therapeutic Agents definition

Therapeutic Agents as used in these rules means any agent approved by the United States Food and Drug Administration (FDA) for use in controlled drug delivery systems in the course of periodontal pocket treatment.
Therapeutic Agents as used herein, means Licensed Products which are in a final formulation, irrespective of concentration or packaging, which could be administered to a patient for therapy.

Examples of Therapeutic Agents in a sentence

  • Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.

  • Barr 9509567 Japan Tanox, Inc APP 11/30/1993 11/30/1994 Methods Of Screening For Therapeutic Agents Using M.

  • Quick-dissolving Oral Thin Film for Targeted Delivery of Therapeutic Agents 61175457 July 15th, 2008 US & PCT Conversion to utility occurred on May 4th, 2009 Aridis Inhalable Process & Formulation for Gallium Compounds 61242376 Sept.

  • Unless otherwise determined, fair market value shall be determined by and be equal to the closing bid price of the Company’s Common Stock in the over-the-counter market on the date the Incentive Stock Option or Non-Qualified Stock Option is granted.

  • UBC INEX [***]% [***]% [***]% XXX-2700-IS Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Icelandic Patent Application No. PCT/CA00/00843 ABANDONED - OCTOBER 19, 2004 Xxxxxx, X.

  • UBC INEX [***]% [***]% [***]% Inex File Number Title Serial/ Patent Numbers Inventors Origin Ownership of Prosecution Hana Cost Allocation UBC Royalty UBC Sublicense Royalty XXX-2700-JP Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Japanese Patent Application No. 2001-510431 PENDING Xxxxxx, X.

  • UBC INEX [***]% [***]% [***]% XXX-2700-DE Methods for Preparation of Lipid-Encapsulated Therapeutic Agents German Patent No. DE 1194122 GRANTED Xxxxxx, X.

  • No. * * Sulfated Non-Ionic Block Copolymer Surfactant as Stabilizer Coatings for Nanoparticle Compositions U.S. 5,569,448 Formulations of Oral Gastrointestinal Therapeutic Agents in Combination with Pharmaceutically Acceptable Clays U.

  • LLNL and Trius jointly responded to a U.S. Health and Human Services (National Institutes of Health) request for proposals (solicitation # BAA NIH-NIAID-DMID 08-20) to develop new therapeutic countermeasures with a proposal entitled “Development of Therapeutic Agents for Select Biodefense Pathogens” which resulted in this CRADA, with a goal of developing gram-negative, dual-target antibacterial agents that show no cross-resistance to existing drugs.

  • UBC INEX [***]% [***]% [***]% XXX-2700-US Methods for Preparation of Lipid-Encapsulated Therapeutic Agents U.S. Patent Application No. 10/019,199 PENDING Xxxxxx, X.

Related to Therapeutic Agents

  • Therapeutic school means a residential group living facility:

  • Therapeutic care means services provided by licensed or certified speech pathologists, Occupational Therapists and Physical Therapists.

  • Biological agent means any microorganism, virus, infectious substance, or biological product that may be engineered through biotechnology, or any naturally occurring or bioengineered component of any such microorganism, virus, infectious substance, or biological product, capable of causing:

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Therapeutic Equivalent means that a Covered Drug can be expected to produce essentially the same therapeutic outcome and toxicity.

  • Active Pharmaceutical Ingredient or “API” shall mean one or more of the following active pharmaceutical ingredients: tenofovir alafenamide (“TAF”), tenofovir disoproxil fumarate (“TDF”), elvitegravir (“EVG”), and cobicistat (“COBI”).

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • Diagnostic x-ray system means an x-ray system designed for irradiation of any part of the human or animal body for the purpose of diagnosis or visualization.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Interchangeable biological product means a biological product that the U.S. Food and Drug Administration has:

  • Diagnostic Services means services provided for the purpose of determining the nature and cause of a condition, ill- ness, or injury.

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

  • Biological agent shall mean any pathogenic (disease producing) micro-organism(s) and/or biologically produced toxin(s) (including genetically modified organisms and chemically synthesized toxins) which cause illness and/or death in humans, animals or plants.